Clinical Trial Update: Chidamide Plus R-CHOP in Newly Diagnosed Double-Expressor Diffuse Large B-Cell Lymphoma With Other Molecular Subtypes [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial assesses chidamide in combination with R-CHOP for newly diagnosed double-expressor diffuse large B-cell lymphoma (with other molecul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Chidamide (chidamide)
• R-CHOP chemotherapy

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Chidamide, R-CHOP Chemotherapy | Phase 2 | Status: RECRUITING